durvalumab,sorafenib,tremelimumab
astrazeneca,pfizer
['himalaya', 'hcc']
22 months (vs. 14 months) os for patients with iraes getting stride regimen in himalaya trial. #hcc #asco23
Medical Director, GI Oncology Program - AdventHealth Cancer Institute. Passionate about clinical research, education and pt-prov communication. #gicancer #meded